ATE548050T1 - Diagnoseverfahren - Google Patents

Diagnoseverfahren

Info

Publication number
ATE548050T1
ATE548050T1 AT08759218T AT08759218T ATE548050T1 AT E548050 T1 ATE548050 T1 AT E548050T1 AT 08759218 T AT08759218 T AT 08759218T AT 08759218 T AT08759218 T AT 08759218T AT E548050 T1 ATE548050 T1 AT E548050T1
Authority
AT
Austria
Prior art keywords
hbp
diagnostic procedure
individual
level
ratio
Prior art date
Application number
AT08759218T
Other languages
German (de)
English (en)
Inventor
Lars Bjorck
Bertil Christensson
Heiko Herwald
Adam Linder
Per Akesson
Original Assignee
Hansa Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38331957&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE548050(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hansa Medical Ab filed Critical Hansa Medical Ab
Application granted granted Critical
Publication of ATE548050T1 publication Critical patent/ATE548050T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
AT08759218T 2007-06-12 2008-06-12 Diagnoseverfahren ATE548050T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0711327.7A GB0711327D0 (en) 2007-06-12 2007-06-12 Diagnostic method
PCT/EP2008/004743 WO2008151808A1 (en) 2007-06-12 2008-06-12 Diagnostic method

Publications (1)

Publication Number Publication Date
ATE548050T1 true ATE548050T1 (de) 2012-03-15

Family

ID=38331957

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08759218T ATE548050T1 (de) 2007-06-12 2008-06-12 Diagnoseverfahren

Country Status (16)

Country Link
US (3) US8518648B2 (enExample)
EP (1) EP2129391B1 (enExample)
JP (1) JP5166522B2 (enExample)
KR (1) KR101563997B1 (enExample)
CN (2) CN103543271A (enExample)
AT (1) ATE548050T1 (enExample)
AU (1) AU2008261252B2 (enExample)
BR (1) BRPI0812875B8 (enExample)
CA (1) CA2690067C (enExample)
DK (1) DK2129391T3 (enExample)
ES (1) ES2380875T3 (enExample)
GB (1) GB0711327D0 (enExample)
PL (1) PL2129391T3 (enExample)
PT (1) PT2129391E (enExample)
SI (1) SI2129391T1 (enExample)
WO (1) WO2008151808A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0711327D0 (en) 2007-06-12 2007-07-25 Hansa Medical Ab Diagnostic method
US20100240049A1 (en) 2009-01-16 2010-09-23 Cepheid Methods of Detecting Cervical Cancer
JP5488885B2 (ja) * 2009-10-28 2014-05-14 国立大学法人 東京大学 感染症の疾患マーカー
GB201016161D0 (en) * 2010-09-24 2010-11-10 Hansa Medical Ab Diagnostic method
EP2643483A4 (en) * 2010-11-26 2014-04-30 Immunexpress Pty Ltd DIAGNOSTIC AND / OR SCREENING APPROPRIATIONS AND USES THEREFOR
GB201102108D0 (en) * 2011-02-07 2011-03-23 Hansa Medical Ab Diagnostic method
AU2012308365A1 (en) * 2011-09-16 2014-04-24 Cepheid Methods of detecting sepsis
US10260111B1 (en) 2014-01-20 2019-04-16 Brett Eric Etchebarne Method of detecting sepsis-related microorganisms and detecting antibiotic-resistant sepsis-related microorganisms in a fluid sample
US10761093B2 (en) 2014-10-09 2020-09-01 Texas Tech University System Microdevice for cell separation utilizing activation phenotype
CN109541235A (zh) * 2018-08-19 2019-03-29 重庆早柒天生物科技股份有限公司 肝素结合蛋白和降钙素原二联检测试剂盒及其制备方法
EP3960758A4 (en) 2019-04-24 2023-02-15 Japanese Foundation For Cancer Research PROCEDURE FOR DETECTING CANCER AND DETECTION REAGENT
CN111208305B (zh) * 2020-02-16 2023-04-25 重庆翼锋生物科技有限公司 Hbp和pct在败血症诊断试剂制备中的用途
CN111951963B (zh) 2020-07-30 2022-09-02 中翰盛泰生物技术股份有限公司 Hbp在covid-19患者的预后风险预警中的应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627262A (en) 1989-07-05 1997-05-06 The Board Of Regents Of The University Of Oklahoma Method and composition for the treatment of septic shock
US5962241A (en) * 1989-07-28 1999-10-05 The University Of Arizona Monoclonal antibody detection of proteins on sperm related to fertility
US5314804A (en) * 1992-03-24 1994-05-24 Serim Research Corporation Test for Helicobacter pylori
NZ332683A (en) 1994-04-21 2001-06-29 Novo Nordisk As Use of heparin binding protein to prevent or treat sepsis
US5976536A (en) 1995-08-09 1999-11-02 Emory University Neisseria mutants, lipooligosaccharides and immunogenic compositions
US5778895A (en) 1997-01-29 1998-07-14 Uab Research Foundation Method of discriminating bacterial from aseptic meningitis
US6303321B1 (en) 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
US20030170745A1 (en) 2002-03-08 2003-09-11 Pereira Heloise Anne Early detection marker for chronic inflammatory associated diseases
US7655480B2 (en) 2002-03-08 2010-02-02 The Board Of Regents Of The University Of Oklahoma Method for predicting sepsis or an acute infectious inflammatory response
EP1581556A2 (en) 2002-08-15 2005-10-05 Leukotech A/S Bactericidal, anti-apoptotic, pro-inflammatory and anti-inflammatory peptides of heparin-binding protein (hbp)
CA2516836A1 (en) * 2003-02-24 2004-09-10 Gtc Biotherapeutics, Inc. Methods of tangential flow filtration and an apparatus therefore
US7191068B2 (en) 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
WO2004112713A2 (en) 2003-06-20 2004-12-29 Royer Biomedical, Inc. Drug polymer complexes
WO2005028512A1 (en) 2003-09-19 2005-03-31 Leukotech A/S Pro-inflammatory and anti-inflammatory antibodies against the heparin-binding protein (hbp)
US20050196817A1 (en) 2004-01-20 2005-09-08 Molecular Staging Inc. Biomarkers for sepsis
BRPI0609302A2 (pt) * 2005-04-15 2011-10-11 Becton Dickinson Co métodos para prever o desenvolvimento de sepse e para diagnosticar sepse em um indivìduo a ser testado, microarranjo, kit para prever o desenvolvimento de sepse em um indivìduo a ser testado, produto de programa de computador, computador, sistema de computador para determinar se um indivìduo é susceptìvel de desenvolver sepse, sinal digital embutido em uma onda portadora, e, interface gráfica de usuário para determinar se um indivìduo é susceptìvel de desenvolver sepse
CA2624569A1 (en) 2005-10-03 2007-04-12 Biosite Incorporated Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
FR2894675B1 (fr) 2005-12-14 2008-06-27 Assist Publ Hopitaux De Paris Distinction des meningites bacteriennes et virales
GB0711327D0 (en) 2007-06-12 2007-07-25 Hansa Medical Ab Diagnostic method
GB201016161D0 (en) 2010-09-24 2010-11-10 Hansa Medical Ab Diagnostic method
GB201102108D0 (en) 2011-02-07 2011-03-23 Hansa Medical Ab Diagnostic method

Also Published As

Publication number Publication date
CA2690067C (en) 2023-09-19
BRPI0812875B1 (pt) 2017-12-05
SI2129391T1 (sl) 2012-07-31
BRPI0812875B8 (pt) 2022-07-12
US20140187503A1 (en) 2014-07-03
US20100305185A1 (en) 2010-12-02
WO2008151808A1 (en) 2008-12-18
GB0711327D0 (en) 2007-07-25
US8518648B2 (en) 2013-08-27
ES2380875T3 (es) 2012-05-21
DK2129391T3 (da) 2012-06-11
CN103543271A (zh) 2014-01-29
JP2010529468A (ja) 2010-08-26
AU2008261252B2 (en) 2013-03-14
BRPI0812875A2 (pt) 2014-12-09
CA2690067A1 (en) 2008-12-18
KR101563997B1 (ko) 2015-10-28
PT2129391E (pt) 2012-06-06
CN101687023B (zh) 2016-04-20
JP5166522B2 (ja) 2013-03-21
EP2129391B1 (en) 2012-03-07
PL2129391T3 (pl) 2012-09-28
US20130252347A1 (en) 2013-09-26
CN101687023A (zh) 2010-03-31
KR20100021578A (ko) 2010-02-25
US9784741B2 (en) 2017-10-10
AU2008261252A1 (en) 2008-12-18
EP2129391A1 (en) 2009-12-09

Similar Documents

Publication Publication Date Title
DK2129391T3 (da) Diagnostisk fremgangsmåde
CY1120961T1 (el) Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος
EA200971131A1 (ru) Биомаркеры для прогнозирования чувствительности или отсутствия чувствительности к анти-фно агентам
ECSP099833A (es) Anticuerpos humanizados contra el globulomero a?(20-42) y sus usos
CO6410314A2 (es) Proteínas de unión a il-17
CY1120434T1 (el) Πρωτεϊνες προσδεσης il-1
EA200970603A1 (ru) Антагонисты активин-actrii и их применения для повышения уровней эритроцитов
MA30497B1 (fr) Anticorps et immunco-conjugues, et leurs utilisations.
UY34736A (es) ?compuestos de indol e indazol que activan la ampk?.
ECSP11011417A (es) Anticuerpos anti-fgfr3 y métodos que los utilizan
CL2010001483A1 (es) Compuestos derivados de 5-fenil-1h-piridin-2-ona y 6-fenil-2h-piridazin-3-ona, inhibidores de tirosina-quinasa (btk); composicion farmaceutica que comprende a dichos compuestos y su uso para el tratamiento de un estado patologico inflamatorio y/o autoinmune.
EA201270553A1 (ru) Ингибиторы тирозинкиназы брутона
EA200701918A1 (ru) Белок липокалин
MA34521B1 (fr) Polypeptides de relaxine modifiés et leurs utilisations
GT200600112A (es) Composiciiones de tigeciclina y metodos de preparacion
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
NO20084320L (no) Antistoffer mot EGFL7 og fremgangsmater for anvendelse av disse
WO2015070001A3 (en) Compositions and methods for detecting and/or treating inflammation
MA44550B1 (fr) Anticorps anti-acide téichoique de la paroi cellulaire et conjugués associés
NZ608316A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
ATE549638T1 (de) 13c-mr-bildgebung oder spektroskopie von zelltod
DE502007005301D1 (de) Verbindungen enthaltend organofluorochlorophosphatanionen
BR112017000490A2 (pt) componente condutor de fluxo
WO2015091902A3 (en) Determination of platelet-mirnas in alzheimer's disease
RU2008105242A (ru) Способ биотестирования загрязнителей (в частности вермипрепаратов)